These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 643579)

  • 41. [Critical analysis of the saralasintest in the diagnosis of hypertension (author's transl)].
    Röckel A; Wernze H; Sabel B; Heidland A
    Klin Wochenschr; 1977 Jul; 55(13):651-6. PubMed ID: 895003
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Haemodynamic effects of Sar1-Ala8-angiotensin II in patients with renovascular hypertension.
    Fagard R; Amery A; Ljnen P; Reybrouck T; Billiet L
    Prog Biochem Pharmacol; 1976; 12():242-9. PubMed ID: 1019167
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Angiotensin II blockade in normal man and patients with essential hypertension. Blood pressure effects depending on renin and sodium balance.
    Brunner HR; Gavras H; Ribeiro AB; Posternak L
    Prog Biochem Pharmacol; 1976; 12():145-62. PubMed ID: 1019161
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Application of the saralasin test to the treatment of malignant or accelerated arterial hypertension (author's transl)].
    Bonnet F; Corvol P; Thibonnier M; Reach G; Lardoux MD; Milliez P
    Nouv Presse Med; 1980 Nov; 9(41):3075-8. PubMed ID: 7443447
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Arterial hypertension and maintenance hemodialysis: effects of specific inhibition of angiotensin II by saralasin acetate].
    Mimran A; Deschodt G; Shaldon S; Barjon P; Mion C
    Arch Mal Coeur Vaiss; 1978 Jul; 71 Spec No():19-24. PubMed ID: 101176
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Role of the renin-angiotensin system in post-transplantation hypertension in patients with multiple kidneys.
    Linas SL; Miller PD; McDonald KM; Stables DP; Katz F; Weil R; Schrier RW
    N Engl J Med; 1978 Jun; 298(26):1440-4. PubMed ID: 349389
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effect of saralasin on plasma aldosterone in hypertensive man.
    Brown RD; Tucker R; Tue K; Wisgerhof M; Salassa R
    J Lab Clin Med; 1978 Mar; 91(3):473-9. PubMed ID: 627750
    [No Abstract]   [Full Text] [Related]  

  • 48. 'Captopril test', with blood pressure and peripheral renin as response variables in hypertensive patients with suspected renal artery stenosis.
    Schreij G; van Es PN; Schiffers PM; Lavrijssen AT; de Leeuw PW
    J Hum Hypertens; 1995 Sep; 9(9):741-6. PubMed ID: 8551488
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effects of saralasin on blood pressure, renin and renal blood flow in unilateral renovascular hypertension.
    Arlart IP; Rosenthal J; Wagner H; Adam WE; Nobbe F; Franz HE
    Contrib Nephrol; 1978; 11():170-4. PubMed ID: 699587
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Renal venous renin in patients with renovascular hypertension.
    Januszewicz W; Filipecki S; Baczko A; Wocial D; Andziak E; Pruszynski B; Rajszys R
    Cor Vasa; 1975; 17(1):32-42. PubMed ID: 1149458
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effect of saralasin on plasma renin activity and arginine-vasopressin in hypertensive man.
    Arlart IP; Rosenthal J; Wagner H; Franz HE
    Proc Eur Dial Transplant Assoc; 1978; 15():412-7. PubMed ID: 740674
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Saralasin in resistant hypertensive crisis (author's transl)].
    Röckel A; Heidland A
    Med Klin; 1979 Mar; 74(11):401-7. PubMed ID: 34782
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Saralasin infusion in screening patients for renovascular hypertension.
    Krakoff LR; Ribeiro AB; Gorkin JU; Felton KR
    Am J Cardiol; 1980 Mar; 45(3):609-13. PubMed ID: 6986750
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Angiotensin II inhibitors for the diagnosis and treatment of hypertension].
    Brunner HR; Gavras H
    Schweiz Med Wochenschr; 1976 Dec; 106(50):1791-8. PubMed ID: 1013701
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [The saralasin test in clinical evaluation of hypertensive states].
    Cremoncini C; Cremoncini M; Libroia A; Vignati E; Botalla L
    Boll Soc Ital Cardiol; 1978; 23(8):1291-7. PubMed ID: 398708
    [No Abstract]   [Full Text] [Related]  

  • 56. The Distinguished Lecture. Is hypertension essential?
    Liddle GW
    Trans Assoc Am Physicians; 1975; 88():55-69. PubMed ID: 131398
    [No Abstract]   [Full Text] [Related]  

  • 57. Sympathetic nerve hyperactivity in high-renin hypertension effects of saralasin infusion.
    DeQuattro V; Barbour BH; Campese V; Finck EJ; Miano L; Esler M
    Mayo Clin Proc; 1977 Jun; 52(6):369-73. PubMed ID: 865132
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A role for renin in rebound hypertension and encephalopathy after infusion of saralasin acetate (Sar1-Ala8-angiotensin II).
    Keim HJ; Drayer JI; Case DB; Lopez-Ovejero J; Wallace JM; Weber MA; Laragh JH
    N Engl J Med; 1976 Nov; 295(21):1175-7. PubMed ID: 980020
    [No Abstract]   [Full Text] [Related]  

  • 59. The use of an angiotensin II antagonist (saralasin) as an adjunct during renal vein catheterization.
    Ibsen H; Giese J; Rabøl A; Kappelgaard AM
    Scand J Clin Lab Invest; 1980 Apr; 40(2):115-20. PubMed ID: 7020064
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Saralasin in human hypertension: the early experience.
    Brunner HR; Laragh JH
    Kidney Int Suppl; 1979 Mar; (9):S36-43. PubMed ID: 289862
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.